http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5174986-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52c8c0e4eed3e07993ce1c1c732bea14
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 1989-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad235563ac85fd83f2f8ef7cc2d425c0
publicationDate 1992-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5174986-A
titleOfInvention Method for determining oncogenic potential of a chemical compound
abstract Methods are provided for determining the oncogenic potential of chemical compounds which utilizes a transgenic mouse predisposed to T-cell lymphomas. The transgenic mouse expresses a pim-1 oncogene and as a consequence is predisposed to the spontaneous onset of T-cell lymphomas. The oncogenic potential of a chemical compound is determined by administering a known dose of the chemical compound of interest to a pim-1 transgenic mouse. Thereafter, the transgenic mouse is monitored to detect the onset of a T-cell lymphoma. The time of onset of the T-cell lymphoma and the dosage of the chemical compound are compared to either the onset of spontaneous T-cell lymphomas in the pim-1 transgenic mouse or to the onset of a T-cell lymphoma in a pim-1 transgenic mouse which has been exposed to a known quantity of a carcinogenic agent. This provides an indication of the oncogenic potential of the chemical compound.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011039265-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010129824-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6407062-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6482929-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7935484-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011207130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5675060-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5723313-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8241848-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6428969-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8192931-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7790395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004092463-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11104958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8257924-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2311951-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10006092-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6350932-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2311950-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8048629-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9540696-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2060630-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2333065-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5814300-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009298085-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7927806-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546551-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008057501-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6033847-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008038743-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010021884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5882894-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6172194-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7935487-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7288380-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9951390-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8361726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010047809-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6258536-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7960109-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5871961-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8618276-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9532285-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9909189-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096907-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6063359-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10752957-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6586203-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8551699-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011212449-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5876965-A
priorityDate 1989-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8905864-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4736866-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129944454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127902459

Total number of triples: 78.